| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/14/2007 | US20070136832 Novel lipoxygenase proteins and polynucleotides encoding the same |
| 06/14/2007 | US20070136831 Selection and cloning methods |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070136827 Cis/trans riboregulators |
| 06/14/2007 | US20070136825 Fusion proteins useful for detecting analytes |
| 06/14/2007 | US20070135625 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 06/14/2007 | US20070135514 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135373 Method for selective expression of therapeutic genes by hyperthermia |
| 06/14/2007 | US20070135372 Modified siRNA molecules and uses thereof |
| 06/14/2007 | US20070135371 Antisense IAP nucleobase oligomers and uses thereof |
| 06/14/2007 | US20070135370 siRNA molecule for silencing Ebola virus L-polymerase (L-pol) expression; nucleic acid-lipid particles suitable for use in intravenous nucleic acid delivery as they are stable in circulation, of a size required for pharmacodynamic behavior resulting in access to extravascular sites, and target cell |
| 06/14/2007 | US20070135369 Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis |
| 06/14/2007 | US20070135367 Method for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 06/14/2007 | US20070135366 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 06/14/2007 | US20070135365 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiovascular disease caused thereby |
| 06/14/2007 | US20070135364 Compositions and methods for the modulation of the expression of b7 protein |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070135336 Follistatin isoforms and uses thereof |
| 06/14/2007 | US20070134831 Programmable mask for fabricating biomolecule array or polymer array, apparatus for fabricating biomolecule array or polymer array including the programmable mask, and method of fabricating biomolecule array or polymer array using the programmable mask |
| 06/14/2007 | US20070134796 Targeted integration and expression of exogenous nucleic acid sequences |
| 06/14/2007 | US20070134795 Flp-mediated recombination |
| 06/14/2007 | US20070134791 Cells for detection of enteroviruses |
| 06/14/2007 | US20070134789 Comprises immature animal cells characterized by expression of alpha-fetoprotein and albumin; extracelluar matrix is formed from collagen, fibronectin, and laminin; solid phase synthesis; for liver transplants |
| 06/14/2007 | US20070134778 Host cell transformed with recombinant enzymes from Arabidopsis thaliana to synthesize 6-sulfo-alpha-D-quinovosyl diaclyglycerol (SQDG) also called sulfoquinovosyldiacylglycerol, KM043 which is a polymerase inhibitor drug; sqdX gene for example |
| 06/14/2007 | US20070134775 Process for producing lactonase and utilization thereof |
| 06/14/2007 | US20070134773 Method for producing l-glutamic acid by fermentation accompanied by precipitation |
| 06/14/2007 | US20070134768 Methods for the preparation of a fine chemical by fermentation |
| 06/14/2007 | US20070134765 Recombinant bacteria and uses thereof |
| 06/14/2007 | US20070134761 Minimal dna sequence acting as a chromatin insulator and its use in protein expression |
| 06/14/2007 | US20070134760 provide alternative host cells comprising multiple copies of a gene of interest, which cells are devoid of antibiotic markers, for use in the industrial production of polypeptides in high yields |
| 06/14/2007 | US20070134759 Process for producing antibody composition by using rna inhibiting the function of alpha1,6-fucosyltransferase |
| 06/14/2007 | US20070134758 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
| 06/14/2007 | US20070134757 Method for cleaving proteins |
| 06/14/2007 | US20070134755 Method of producing cell extract for cell-free protein synthesis |
| 06/14/2007 | US20070134750 Glucose dehydrogenase |
| 06/14/2007 | US20070134749 Protein tyrosine kinase substrate lat and its use in the identification of (ANT)agonists of the kinase |
| 06/14/2007 | US20070134745 Using cytokine receptor-16 expression as evaluative tool in diagnosis of cell proliferative disorders |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134727 Antibodies to cytokine receptor |
| 06/14/2007 | US20070134717 Oxaloacetate hydrolase deficient fungal host cells |
| 06/14/2007 | US20070134712 Gene examining apparatus and method of detecting target nucleic acid using the same |
| 06/14/2007 | US20070134706 Gene information display method and apparatus |
| 06/14/2007 | US20070134703 Chromophores/fluorophores and methods for using the same |
| 06/14/2007 | US20070134698 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response |
| 06/14/2007 | US20070134697 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134682 method for the selection of nucleic acid polymerases and other enzymes; used for the selection of enzymes comprising low catalytic turnover, low processivity, polymerases which incorporate modified replication-blocking nucleotide that cannot be replicated and polymerases with a high-error rate |
| 06/14/2007 | US20070134680 Lipid metabolism molecules |
| 06/14/2007 | US20070134674 Method for the prognosis and/or diagnosis of a cancer |
| 06/14/2007 | US20070134673 detecting a subject of Chinese descent suffering from, at risk for developing, or suspected of suffering from a nephropathy by detecting angiotensin converting enzyme (ACE) gene, a (z-2) genotype of an aldose reductase (ALR2) gene 5'-(CA) repeats, and a C106T genotype of an ALR2 gene in promoter region |
| 06/14/2007 | US20070134664 Human autism susceptibility gene and uses thereof |
| 06/14/2007 | US20070134657 Methods and compositions relating to gradient exposed cells |
| 06/14/2007 | US20070134655 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half |
| 06/14/2007 | US20070134271 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 06/14/2007 | US20070134267 Tuberculosis vaccine with improved efficacy |
| 06/14/2007 | US20070134263 Grampositive immunogen protein for use in developing vaccine for prevention of microorganismal infection; immunization |
| 06/14/2007 | US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus |
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/14/2007 | US20070134256 Chimpanzee Fab antibodies against DENV-4; isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith |
| 06/14/2007 | US20070134252 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | US20070134241 Humanized anti-CD3 specific antibodies |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134237 Human cytokine receptor |
| 06/14/2007 | US20070134228 Immunoaffinity purification |
| 06/14/2007 | US20070134227 Catalyst for cleaving sugar chain |
| 06/14/2007 | US20070134226 Heparan sulfate glycosaminoglycan lyase and uses thereof |
| 06/14/2007 | US20070134217 Using transposon vector as gene transfer and amplification tool; gene therapy |
| 06/14/2007 | US20070134214 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 06/14/2007 | US20070134205 Gene delivery of detoxifying agent |
| 06/14/2007 | US20070134204 Method for treating nerve injury and vector construct for the same |
| 06/14/2007 | US20070134203 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/14/2007 | US20070134202 Cancer gene therapeutic drug |
| 06/14/2007 | US20070134201 Archaeon expression system |
| 06/14/2007 | US20070134200 Immunogenic composition and methods |
| 06/14/2007 | US20070134188 Double-stranded RNA oligonucleotides which inhibit tyrosinase expression |
| 06/14/2007 | US20070132535 Electromagnetic device, high-voltage generating device, and method for making the electromagnetic device |
| 06/14/2007 | DE102005059315A1 Verfahren zur Anreicherung von kurzkettigen Nukleinsäuren A method for enrichment of short-chain nucleic acids |
| 06/14/2007 | DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy |
| 06/14/2007 | DE102005059217A1 Verfahren und Testkit zur Trennung, Aufreinigung und Wiedergewinnung von lang- und kurzkettigen Nukleinsäuren Method and kit for separation, purification and recovery of long- and short-chain nucleic acids |
| 06/14/2007 | DE102005026045A1 Nukleinsäure, die für ein autoaktiviertes Resistenzprotein zur Erzeugung einer Resistenz gegenüber Pathogenen bei Pflanzen codiert Nucleic acid which codes for an autoactivated resistance protein for creating a resistance to pathogens in plants |
| 06/14/2007 | DE102004013955B4 Verfahren zur Herstellung von rekombinanter RNase A A process for the production of recombinant RNase A |
| 06/14/2007 | CA2800283A1 A novel 40 kda lipase from tetrasphaera |
| 06/14/2007 | CA2642657A1 Method for replicating nucleic acids and novel unnatural base pairs |
| 06/14/2007 | CA2633847A1 A novel 32 kda lipase from tetrasphaera |
| 06/14/2007 | CA2632888A1 Immunogenic composition based on conditionally live virion and method for producing the same |
| 06/14/2007 | CA2632723A1 Nucleic acids and methods for producing seeds having a full diploid complement of the maternal genome in the embryo |
| 06/14/2007 | CA2632534A1 Methods for producing ceramide using transformed yeast |
| 06/14/2007 | CA2632456A1 An hiv-1 latency model for high throughput screening |
| 06/14/2007 | CA2632419A1 Genetically recombinant anti-perp antibody |
| 06/14/2007 | CA2632405A1 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii |
| 06/14/2007 | CA2632402A1 Treatment of epstein-barr virus-associated diseases |
| 06/14/2007 | CA2631785A1 Methods for generating antigen-specific effector t cells |
| 06/14/2007 | CA2631706A1 Methods of identifying agents that modulate mitochondrial function |
| 06/14/2007 | CA2630904A1 Compositions and methods for therapy and diagnosis of cancer |